Organoid Technologies for the Study of Intestinal Microbiota-host Interactions
Overview
Authors
Affiliations
Postbiotics have recently emerged as critical effectors of the activity of probiotics and, because of their safety profile, they are considered potential therapeutics for the treatment of fragile patients. Here, we present recent studies on probiotics and postbiotics in the context of novel discovery tools, such as organoids and organoid-based platforms, and nontransformed preclinical models, that can be generated from intestinal stem cells. The implementation of organoid-related techniques is the next gold standard for unraveling the effect of microbial communities on homeostasis, inflammation, idiopathic diseases, and cancer in the gut. We also summarize recent studies on biotics in organoid-based models and offer our perspective on future directions.
Microbes Saving Lives and Reducing Suffering.
Timmis K, Karahan Z, Ramos J, Koren O, Perez-Cobas A, Steward K Microb Biotechnol. 2025; 18(1):e70068.
PMID: 39844583 PMC: 11754571. DOI: 10.1111/1751-7915.70068.
Experimental models of antibiotic exposure and atopic disease.
Donald K, Finlay B Front Allergy. 2024; 5:1455438.
PMID: 39525399 PMC: 11543581. DOI: 10.3389/falgy.2024.1455438.
Yao Q, Cheng S, Pan Q, Yu J, Cao G, Li L MedComm (2020). 2024; 5(10):e735.
PMID: 39309690 PMC: 11416091. DOI: 10.1002/mco2.735.
Yang Z, Yu J, Wong C Cells. 2024; 13(16.
PMID: 39195202 PMC: 11352269. DOI: 10.3390/cells13161312.
() : a probiotic candidate to reduce neonatal diarrhea in calves.
Schwaiger K, Storch J, Bauer C, Bauer J Front Microbiol. 2023; 14:1266905.
PMID: 37854332 PMC: 10579909. DOI: 10.3389/fmicb.2023.1266905.